Evidence map›Paper›PMID 39068253›Full record

ArticleJournal of cancer research and clinical oncology2024

Exploring the impact of body mass index on tumor biology and cancer development.

Johanne Ahrenfeldt, Stine Carstensen, Ida Maria Hemdorff Eriksen, Nicolai Juul Birkbak

Abstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Johanne AhrenfeldtDepartment of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
Stine CarstensenDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Ida Maria Hemdorff EriksenDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Nicolai Juul BirkbakDepartment of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. nbirkbak@clin.au.dk.

Funding

Lundbeck Foundation R272-2017-4040Novo Nordisk Fonden NNF21OC0071483
6 · The paper itself

Abstract

purposeCancer continues to be a major global health challenge, affecting millions of individuals and placing substantial burdens on healthcare systems worldwide. Recent research suggests a complex relationship between obesity and cancer, with obesity increasing the risk of various cancers while potentially improving outcomes for diagnosed patients, a phenomenon termed the "obesity paradox". In this study, we used a cohort of 1781 patients to investigate the impact of obesity on tumor characteristics, including gene expression, pathway dysfunction, genetic alterations and immune infiltration.

methodsPatient samples spanned 10 different cancer types, and were obtained from the Cancer Genome Atlas, with annotations for body mass index (BMI), age, sex, tumor size and tumor gene expression data.

resultsWhen we compared the proportion of large (T3-T4) to small tumors (T1-T2) between obese and non-obese patients, we found that obese patients tended to present with smaller, less invasive tumors and exhibited distinct gene expression profiles, particularly in metabolic and proliferative pathways. Moreover, smaller tumors in obese patients show higher immune cell infiltration and increased T cell diversity, suggesting enhanced immune activity.

conclusionTaken together, these findings highlight the influence of obesity on tumor biology, with implications for personalized treatment strategies that consider patient physiology alongside tumor characteristics.

Indexed as

Body Mass IndexNeoplasmsObesityAdultAgedCohort StudiesFemaleHumansMaleMiddle AgedCancer and obesityPathway analysisTranscriptomicsTumor aggresivenessTumor biology

Identifiers

PMID39068253
PMCPMC11283407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.